免费电话：400-668-6834 | 技术支持：400-168-6834 | 邮箱：info@selleck.cn

PD-1/PD-L1治疗性抗体（Pembrolizumab，Atezolizumab，Nivolumab）重磅上市！

首页
抑制剂
- 研究领域
- PI3K/Akt/mTOR
  - PI3K
  - mTOR
  - Akt
  - GSK-3
  - ATM/ATR
  - PDK
  - S6 Kinase
  - AMPK
  - DNA-PK
  - MELK
  - PIKfyve
  - PI4K
- Epigenetics
- Methylation
  - DNA Methyltransferase
  - LSD1
  - DOT1
  - COMT
  - EZH1/2
  - PPMTase
  - MLL
  - SAM MTase
  - SETD
  - WDR5
  - PRMT
  - G9a/GLP
  - SMYD2
  - JMJD
  - HNMT
- Immunology & Inflammation
  - PD-1/PD-L1
  - COX
  - CCR
  - Histamine Receptor
  - IL Receptor
  - ROS
  - IDO/TDO
  - TLR
  - NOS
  - NADPH-oxidase
  - Leukotriene Receptor
  - MALT
  - CXCR
  - gp120/CD4
  - Nrf2
  - Immunology & Inflammation related
  - Prostaglandin Receptor
  - STING
  - Galectin
- Protein Tyrosine Kinase
  - VEGFR
  - EGFR
  - PDGFR
  - c-Met
  - HER2
  - IGF-1R
  - FLT3
  - FGFR
  - c-Kit
  - Src
  - ALK
  - Tie-2
  - c-RET
  - ACK
  - Axl
  - Ephrin Receptor
  - CSF-1R
  - Trk receptor
  - BTK
- Angiogenesis
  - VEGFR
  - JAK
  - EGFR
  - PDGFR
  - HER2
  - FLT3
  - FGFR
  - HIF
  - VDA
  - Bcr-Abl
  - Src
  - ALK
  - Syk
  - FAK
  - BTK
- Apoptosis
  - PD-1/PD-L1
  - Bcl-2
  - Caspase
  - p53
  - TNF-alpha
  - Mdm2
  - Survivin
  - c-RET
  - IAP
  - PERK
  - ASK
  - Serine/threonin kinase
  - Bcl-6
- Autophagy
  - Autophagy
  - CXCR
  - LRRK2
- ER stress & UPR
  - JNK
  - HSP e.g. HSP90
  - PERK
  - ASK
  - IRE1
  - PDI
- JAK/STAT
  - JAK
  - STAT
  - EGFR
  - Pim
- MAPK
  - MEK
  - Raf
  - p38 MAPK
  - JNK
  - TOPK
  - MNK
  - ERK
  - TAK1
  - Mixed Lineage Kinase
- Cytoskeletal Signaling
  - Akt
  - Wnt/beta-catenin
  - Bcr-Abl
  - PKC
  - FAK
  - HSP e.g. HSP90
  - Kinesin
  - Microtubule Associated
  - Integrin
  - PAK
  - Dynamin
- Cell Cycle
  - CDK
  - PD-1/PD-L1
  - Aurora Kinase
  - Chk
  - ROCK
  - PLK
  - APC
  - Wee1
  - Rho
  - c-Myc
  - DYRK
  - BMI-1
- TGF-beta/Smad
  - TGF-beta/Smad
  - Bcr-Abl
  - PKC
  - ROCK
- DNA Damage
  - HDAC
  - ATM/ATR
  - PARP
  - DNA/RNA Synthesis
  - Sirtuin
  - Topoisomerase
  - DNA-PK
  - Telomerase
  - MTH1
  - High-mobility Group
  - DNA alkylator
  - RAD51
  - CRISPR/Cas9
  - BMI-1
- Stem Cells & Wnt
- Ubiquitin
  - Proteasome
  - DUB
  - p97
  - SUMO
  - E2 conjugating
  - E1 Activating
  - E3 Ligase
- Neuronal Signaling
  - Beta Amyloid
  - 5-HT Receptor
  - COX
  - Gamma-secretase
  - GluR
  - Adrenergic Receptor
  - AChR
  - Histamine Receptor
  - Dopamine Receptor
  - Opioid Receptor
  - GABA Receptor
  - P-gp
  - P2 Receptor
  - OX Receptor
  - MT Receptor
  - GlyT
  - NMDAR
  - CaMK
  - Trk receptor
  - Substance P
  - BACE
- NF-κB
  - HDAC
  - NF-κB
  - IκB/IKK
  - NOD1
- GPCR & G Protein
- Endocrinology & Hormones
- Transmembrane Transporters
  - Calcium Channel
  - Sodium Channel
  - ATPase
  - Chloride Channel
  - Potassium Channel
  - GABA Receptor
  - P-gp
  - Proton Pump
  - CFTR
  - TRPV
  - CRM1
  - OCT
  - MCT
  - Amino acid transporter
- Metabolism
  - PPAR
  - P450 (e.g. CYP17)
  - HSP e.g. HSP90
  - PDE
  - Hydroxylase
  - Factor Xa
  - DHFR
  - Dehydrogenase
  - Procollagen C Proteinase
  - Phospholipase (e.g. PLA)
  - Carbonic Anhydrase
  - MAO
  - Liver X Receptor
  - FAAH
  - AhR
  - FXR
  - Vitamin
  - PKM
  - Ferroptosis
  - Thioredoxin
  - FOX
  - Lipoxygenase
  - HMG-CoA Reductase
  - Lipase
  - Fatty Acid Synthase
  - NAMPT
  - LDL
  - Casein Kinase
  - GLUT
  - CETP
  - IDO/TDO
  - Retinoid Receptor
  - Decarboxylase
  - Transferase
  - AdipoR
  - ATP-citrate lyase
  - Carbohydrate Metabolism
- Proteases
- Microbiology
- Others
  - Phosphorylase
  - Thrombin
  - PTEN
  - phosphatase
  - Others
- 产品类型
- Pfizer辉瑞授权化合物
- API
- 天然产物
- 抑制剂组合
- 多肽合成
- Eukaryotic Selection Antibiotics
- 所有靶点(A-Z)
- 所有产品(A-Z)
化合物分子库
动物实验抗体
新产品
联系我们

Stemness kinase

抑制剂选择性比较

Stemness kinase产品

所有产品 Stemness kinase抑制剂(1)

产品目录

产品描述

文献引用

实验数据

S8572

Amcasertib (BBI503)

Amcasertib (BBI503)是一种cancer stemness kinase抑制剂，抑制Nanog和其他癌症干细胞通路，具有潜在的抗癌活性。

产品目录

产品描述

文献引用

实验数据

S8572

Amcasertib (BBI503)

Amcasertib (BBI503)是一种cancer stemness kinase抑制剂，抑制Nanog和其他癌症干细胞通路，具有潜在的抗癌活性。

Tags: Stemness kinase Inhibition | Stemness kinase Activation | Stemness kinase Inhibitor | Stemness kinase activator | Stemness kinase Activity | Stemness kinase phosphorylation| CSC pathway